
Wei Qiang Seow - Research Fellow - A*STAR - LinkedIn
Experience: A*STAR - Agency for Science, Technology and Research · Education: University of Cambridge · Location: San Francisco Bay Area · 149 connections on LinkedIn. View Wei …
- Connections: 149
- Location: A*STAR - Agency for Science, Technology and Research
Wei Qiang SEOW | Postdoctoral Fellow - ResearchGate
I currently work at Stanford University's Department of Dermatology. I do research in Genetics, Genomics, Biotechnology, and Bioinformatics. My current interests are in chromatin...
Publications — Greenleaf Lab - Stanford
Wilson Lek Wen Tan, Wei Qiang Seow, Angela Zhang, Siyeon Rhee, Wing H. Wong, William J. Greenleaf, Joseph C. Wu (2023) Nature Cardiovascular Research. Single-cell technology has …
CLOuD9: CRISPR-Cas9-Mediated Technique for Reversible
Here, we present CLOuD9, a CRISPR-based technology that can create de novo, pairwise chromatin interactions in cells. This technique for chromatin loop reorganization employs …
Current and future perspectives of single-cell multi-omics …
Jan 18, 2023 · Here, we highlight the recent remarkable progress in using single-cell technology to study transcriptomic and epigenetic heterogeneity in cardiac disease and development. We …
Accessible Region Conformation Capture (ARC-C) gives high
To address this, we developed Accessible Region Conformation Capture (ARC-C), which profiles interactions between regulatory elements genome-wide without a capture step. Applied to …
Wei Qiang Seow (0000-0002-5019-9332) - ORCID
Jun 1, 2022 · Wei Qiang Seow Stanford University: Stanford, CA, US 2019-05-01 to 2022-04-30 | Postdoctoral Scholar (Dermatology)
Platform for the interdisciplinary study of cardiovascular, metabolic ...
Nov 22, 2023 · We hypothesise that quantifiable metabolic inflexibility may be representative of an individual in his/her silent, but high-risk progression towards insulin resistance, diabetes and …
Current and future perspectives of single-cell multi-omics
Single-cell technology has become an indispensable tool in cardiovascular research since its first introduction in 2009. Here, we highlight the recent remarkable progress in using single-cell …
CLOuD9: CRISPR-Cas9-Mediated Technique for Reversible
Jul 23, 2022 · Here, we present CLOuD9, a CRISPR-based technology that can create de novo, pairwise chromatin interactions in cells. This technique for chromatin loop reorganization …
- Some results have been removed